Leveraging telecommuting pharmacists in the post-COVID-19 world.
J Am Pharm Assoc (2003)
; 60(6): e113-e115, 2020.
Article
in English
| MEDLINE | ID: covidwho-731813
ABSTRACT
In response to the coronavirus disease 2019 (COVID-19) pandemic, many industries, including pharmacy, rapidly expanded the use of telecommuting workers to assure business continuity and address social distancing needs. Advances in electronic health records and telepharmacy over the past 2 decades enabled pharmacy leaders to easily adapt their practice models to allow for telecommuting alternatives during the pandemic. While these changes were generally intended to be part of the short-term response, the sustained expansion of telecommuting within the pharmacy profession merits further exploration. Documented experience with telepharmacy and telehealth indicate a wide array of clinical and operational pharmacist activities that could be conducted by telecommuters. In addition, experience with telecommuters in other industries suggests potential benefits ranging from improving pharmacists' work-life balance to mitigating postpandemic financial burden. Health care organizations should consider integrating part-time telecommuter pharmacists into contemporary practice models to address other frontline issues and facilitate ongoing expansion of clinical pharmacy services to meet emerging patient needs.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pharmacists
/
Pharmaceutical Services
/
Telecommunications
/
Professional Role
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Topics:
Long Covid
Language:
English
Journal:
J Am Pharm Assoc (2003)
Journal subject:
Pharmacy
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS